{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:39:47Z","timestamp":1790390387509,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["601\/14"],"award-info":[{"award-number":["601\/14"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001742","name":"United States-Israel Binational Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA211752"],"award-info":[{"award-number":["CA211752"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1093\/jnci\/djy032","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T15:10:15Z","timestamp":1519830615000},"page":"1102-1114","source":"Crossref","is-referenced-by-count":42,"title":["Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications"],"prefix":"10.1093","volume":"110","author":[{"given":"Uri","family":"Barash","sequence":"first","affiliation":[{"name":"Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Lapidot","sequence":"additional","affiliation":[{"name":"Departments of General Thoracic Surgery, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaniv","family":"Zohar","sequence":"additional","affiliation":[{"name":"Departments of Pathology Rambam Health Care Campus, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Loomis","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Langone Medical Center, New York University School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Moreira","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Langone Medical Center, New York University School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Feld","sequence":"additional","affiliation":[{"name":"Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Goparaju","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Langone Medical Center, New York University School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Yang","sequence":"additional","affiliation":[{"name":"University of Hawaii Cancer Center, Honolulu, HI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Hammond","sequence":"additional","affiliation":[{"name":"Zucero Therapeutics, Darra, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganlin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Hospital of Traditional Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry and Microbiology, University of Uppsala, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neta","family":"Ilan","sequence":"additional","affiliation":[{"name":"Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[{"name":"Department of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey I","family":"Pass","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Langone Medical Center, New York University School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Vlodavsky","sequence":"additional","affiliation":[{"name":"Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,21]]},"reference":[{"key":"key\n\t\t\t\t2018112207024291100_djy032-B1","first-page":"729","article-title":"Functions of cell surface heparan sulfate proteoglycans","volume":"68","author":"Bernfield","year":"1999","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"key\n\t\t\t\t2018112207024291100_djy032-B2","first-page":"123","article-title":"Supramolecular assembly of basement membranes","volume":"18","author":"Timpl","year":"1996","journal-title":"Bioessays."},{"key":"key\n\t\t\t\t2018112207024291100_djy032-B3","first-page":"530","article-title":"Heparan sulphate proteoglycans: The sweet side of development","volume":"6","author":"Udo Hacker KNaNP","year":"2005","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"7","key":"key\n\t\t\t\t2018112207024291100_djy032-B4","first-page":"793","article-title":"Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis","volume":"5","author":"Vlodavsky","year":"1999","journal-title":"Nat Med."},{"issue":"19","key":"key\n\t\t\t\t2018112207024291100_djy032-B5","first-page":"3890","article-title":"Proteoglycans in health and disease: New concepts for heparanase function in tumor progression and metastasis","volume":"277","author":"Barash","year":"2010","journal-title":"Febs J."},{"issue":"2","key":"key\n\t\t\t\t2018112207024291100_djy032-B6","first-page":"115","article-title":"Significance of heparanase in cancer and inflammation","volume":"5","author":"Vlodavsky","year":"2012","journal-title":"Cancer Microenviron"},{"issue":"12","key":"key\n\t\t\t\t2018112207024291100_djy032-B7","first-page":"2018","article-title":"Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis","volume":"38","author":"Ilan","year":"2006","journal-title":"Int J Biochem Cell Biol."},{"issue":"3","key":"key\n\t\t\t\t2018112207024291100_djy032-B8","first-page":"427","article-title":"Mammalian heparanase: What is the message?","volume":"11","author":"Vreys","year":"2007","journal-title":"J Cell Mol Med."},{"issue":"16","key":"key\n\t\t\t\t2018112207024291100_djy032-B9","first-page":"1219","article-title":"Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis","volume":"96","author":"Edovitsky","year":"2004","journal-title":"J Natl Cancer Inst."},{"issue":"2","key":"key\n\t\t\t\t2018112207024291100_djy032-B10","first-page":"253","article-title":"The heparanase system and tumor metastasis: Is heparanase the seed and soil?","volume":"30","author":"Arvatz","year":"2011","journal-title":"Cancer Metastasis Rev."},{"issue":"11","key":"key\n\t\t\t\t2018112207024291100_djy032-B11","first-page":"2178","article-title":"Heparanase enhances myeloma progression via CXCL10 downregulation","volume":"28","author":"Barash","year":"2014","journal-title":"Leukemia."},{"key":"key\n\t\t\t\t2018112207024291100_djy032-B12","first-page":"91","article-title":"Targeting heparanase to the mammary epithelium enhances mammary gland development and promotes tumor growth and metastasis","volume":"65","author":"Boyango","year":"2018","journal-title":"Matrix Biol"},{"key":"key\n\t\t\t\t2018112207024291100_djy032-B13","first-page":"4504","article-title":"Heparanase cooperates with Ras to drive breast and skin tumorigenesis","volume":"74","author":"Boyango","year":"2014","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t2018112207024291100_djy032-B14","first-page":"1598","article-title":"Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma","volume":"7","author":"Ramani","year":"2016","journal-title":"Oncotarget."},{"issue":"18","key":"key\n\t\t\t\t2018112207024291100_djy032-B15","first-page":"3946","article-title":"Heparanase enhances tumor growth and chemoresistance by promoting autophagy","volume":"75","author":"Shteingauz","year":"2015","journal-title":"Cancer Res."},{"issue":"6","key":"key\n\t\t\t\t2018112207024291100_djy032-B16","first-page":"693","article-title":"The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation","volume":"4","author":"Ferro","year":"2004","journal-title":"Mini Rev Med Chem."},{"issue":"6","key":"key\n\t\t\t\t2018112207024291100_djy032-B17","first-page":"1382","article-title":"SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase\/syndecan-1 axis","volume":"17","author":"Ritchie","year":"2011","journal-title":"Clin Cancer Res."},{"issue":"20","key":"key\n\t\t\t\t2018112207024291100_djy032-B18","first-page":"2057","article-title":"Heparanase: Structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate","volume":"13","author":"Vlodavsky","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"48","key":"key\n\t\t\t\t2018112207024291100_djy032-B19","first-page":"E7808","article-title":"Heparanase is required for activation and function of macrophages","volume":"113","author":"Gutter-Kapon","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"key\n\t\t\t\t2018112207024291100_djy032-B20","first-page":"1709","article-title":"Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice","volume":"121","author":"Lerner","year":"2011","journal-title":"J Clin Invest."},{"issue":"1","key":"key\n\t\t\t\t2018112207024291100_djy032-B21","first-page":"44","article-title":"Malignant mesothelioma: Facts, myths, and hypotheses","volume":"227","author":"Carbone","year":"2012","journal-title":"J Cell Physiol."},{"issue":"7","key":"key\n\t\t\t\t2018112207024291100_djy032-B22","first-page":"1413","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis."},{"issue":"5","key":"key\n\t\t\t\t2018112207024291100_djy032-B23","first-page":"633","article-title":"Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies","volume":"9","author":"Bononi","year":"2015","journal-title":"Exp Rev Respir Med."},{"issue":"8","key":"key\n\t\t\t\t2018112207024291100_djy032-B24","first-page":"475","article-title":"Novel insights into mesothelioma biology and implications for therapy","volume":"17","author":"Yap","year":"2017","journal-title":"Nat Rev Cancer."},{"issue":"5","key":"key\n\t\t\t\t2018112207024291100_djy032-B25","first-page":"469","article-title":"Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma","volume":"21","author":"Davidson","year":"2004","journal-title":"Clin Exp Metast."},{"issue":"1","key":"key\n\t\t\t\t2018112207024291100_djy032-B26","first-page":"13","article-title":"Heparanase expression: A potential ancillary diagnostic tool for distinguishing between malignant cells and reactive mesothelium in body cavity effusions","volume":"18","author":"Doviner","year":"2007","journal-title":"Cytopathology."},{"issue":"3","key":"key\n\t\t\t\t2018112207024291100_djy032-B27","first-page":"704","article-title":"Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis","volume":"113","author":"Weissmann","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"key\n\t\t\t\t2018112207024291100_djy032-B28","first-page":"e5181","article-title":"Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases","volume":"4","author":"Zcharia","year":"2009","journal-title":"PLoS One."},{"issue":"4","key":"key\n\t\t\t\t2018112207024291100_djy032-B29","first-page":"635","article-title":"PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models","volume":"104","author":"Dredge","year":"2011","journal-title":"Br J Cancer."},{"issue":"37","key":"key\n\t\t\t\t2018112207024291100_djy032-B30","first-page":"13613","article-title":"Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins","volume":"101","author":"Aoki","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"key\n\t\t\t\t2018112207024291100_djy032-B31","first-page":"4969","article-title":"Post-transcriptional regulation of heparanase gene expression by a 3' AU-rich element","volume":"24","author":"Arvatz","year":"2011","journal-title":"Faseb J."},{"issue":"4","key":"key\n\t\t\t\t2018112207024291100_djy032-B32","first-page":"365","article-title":"Use of defibrotide in the treatment and prevention of veno-occlusive disease","volume":"2","author":"Richardson","year":"2009","journal-title":"Exp Rev Hematol."},{"issue":"3","key":"key\n\t\t\t\t2018112207024291100_djy032-B33","first-page":"400","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Risk factors and stratification, prophylaxis, and treatment","volume":"22","author":"Dalle","year":"2016","journal-title":"Biol Blood Marrow Tranplant"},{"issue":"12","key":"key\n\t\t\t\t2018112207024291100_djy032-B34","first-page":"2112","article-title":"The IASLC Mesothelioma Staging Project: Proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for mesothelioma","volume":"11","author":"Rusch","year":"2016","journal-title":"J Thorac Oncol."},{"key":"key\n\t\t\t\t2018112207024291100_djy032-B35","first-page":"22","article-title":"Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype","volume":"55","author":"Ramani","year":"2016","journal-title":"Matrix Biol."},{"issue":"3","key":"key\n\t\t\t\t2018112207024291100_djy032-B36","first-page":"1455","article-title":"Heparanase induces vascular endothelial growth factor expression: Correlation with p38 phosphorylation levels and Src activation","volume":"66","author":"Zetser","year":"2006","journal-title":"Cancer Res."},{"issue":"10026","key":"key\n\t\t\t\t2018112207024291100_djy032-B37","first-page":"1405","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): A randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet."},{"issue":"1","key":"key\n\t\t\t\t2018112207024291100_djy032-B38","first-page":"54","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours","volume":"81","author":"Ohta","year":"1999","journal-title":"Br J Cancer."},{"issue":"6","key":"key\n\t\t\t\t2018112207024291100_djy032-B39","first-page":"e1009285","article-title":"The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers","volume":"4","author":"Ujiie","year":"2015","journal-title":"Oncoimmunology."},{"issue":"4","key":"key\n\t\t\t\t2018112207024291100_djy032-B40","first-page":"705","article-title":"Dual role of macrophages in tumor growth and angiogenesis","volume":"80","author":"Lamagna","year":"2006","journal-title":"J Leukoc Biol."},{"issue":"6","key":"key\n\t\t\t\t2018112207024291100_djy032-B41","first-page":"400","article-title":"p21 in cancer: Intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat Rev Cancer."},{"key":"key\n\t\t\t\t2018112207024291100_djy032-B42","first-page":"e19","article-title":"P21 and p27: Roles in carcinogenesis and drug resistance","volume":"10","author":"Abukhdeir","year":"2008","journal-title":"Exp Rev Mol Med."},{"issue":"3","key":"key\n\t\t\t\t2018112207024291100_djy032-B43","first-page":"175","article-title":"The heparanase inhibitor PG545 attenuates colon cancer initiation and growth, associating with increased p21 expression","volume":"19","author":"Singh","year":"2017","journal-title":"Neoplasia."},{"issue":"7","key":"key\n\t\t\t\t2018112207024291100_djy032-B44","first-page":"879","article-title":"PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples","volume":"51","author":"Winterhoff","year":"2015","journal-title":"Eur J Cancer."},{"issue":"2","key":"key\n\t\t\t\t2018112207024291100_djy032-B45","first-page":"133","article-title":"Asbestos, lung cancers, and mesotheliomas: From molecular approaches to targeting tumor survival pathways","volume":"42","author":"Heintz","year":"2010","journal-title":"Am J Respir Cell Mol Biol."}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/110\/10\/1102\/26692370\/djy032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T07:03:30Z","timestamp":1542870210000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/110\/10\/1102\/4951756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,21]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,3,21]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djy032","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10]]},"published":{"date-parts":[[2018,3,21]]}}}